These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 12010858

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.
    Oncogene; 1999 Feb 11; 18(6):1313-24. PubMed ID: 10022813
    [Abstract] [Full Text] [Related]

  • 26. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 27. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.
    Clin Cancer Res; 2003 Jul 01; 9(7):2673-7. PubMed ID: 12855646
    [Abstract] [Full Text] [Related]

  • 28. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ.
    Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822
    [Abstract] [Full Text] [Related]

  • 29. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 07; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 30. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 31. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
    Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD.
    Prostate; 2002 Jun 01; 51(4):225-30. PubMed ID: 11987150
    [Abstract] [Full Text] [Related]

  • 32. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8321-5. PubMed ID: 16322291
    [Abstract] [Full Text] [Related]

  • 33. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1274-8. PubMed ID: 15894685
    [Abstract] [Full Text] [Related]

  • 34. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
    Chan QK, Khoo US, Ngan HY, Yang CQ, Xue WC, Chan KY, Chiu PM, Ip PP, Cheung AN.
    Clin Cancer Res; 2005 Apr 15; 11(8):2981-5. PubMed ID: 15837751
    [Abstract] [Full Text] [Related]

  • 35. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM.
    Mol Cell Probes; 2000 Aug 15; 14(4):211-7. PubMed ID: 10970725
    [Abstract] [Full Text] [Related]

  • 36. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
    Eilers T, Machtens S, Tezval H, Blaue C, Lichtinghagen R, Hagemann J, Jonas U, Serth J.
    Prostate; 2007 May 15; 67(7):757-63. PubMed ID: 17373715
    [Abstract] [Full Text] [Related]

  • 37. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
    Bryzgunova OE, Morozkin ES, Yarmoschuk SV, Vlassov VV, Laktionov PP.
    Ann N Y Acad Sci; 2008 Aug 15; 1137():222-5. PubMed ID: 18837951
    [Abstract] [Full Text] [Related]

  • 38. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 15; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 39. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Nelson CP, Kidd LC, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW.
    Cancer Res; 2001 Jan 01; 61(1):103-9. PubMed ID: 11196146
    [Abstract] [Full Text] [Related]

  • 40. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 01; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.